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Abstract
Introduction
The increased availability of influenza surveillance data in recent years justifies an actual
and more complete overview of influenza epidemiology in Latin America. We compared the
influenza surveillance systems and assessed the epidemiology of influenza A and B, includ-
ing the spatio-temporal patterns of influenza epidemics, in ten countries and sub-national
regions in Latin America.
Methods
We aggregated the data by year and country and characteristics of eighty-two years were
analysed. We calculated the median proportion of laboratory-confirmed influenza cases
caused by each virus strain, and compared the timing and amplitude of the primary and sec-
ondary peaks between countries.
Results
37,087 influenza cases were reported during 2004–2012. Influenza A and B accounted for a
median of 79% and, respectively, 21% of cases in a year. The percentage of influenza A
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cases that were subtyped was 82.5%; for influenza B, 15.6% of cases were characterized.
Influenza A and B were dominant in seventy-five (91%) and seven (9%) years, respectively.
In half (51%) of the influenza A years, influenza A(H3N2) was dominant, followed by influ-
enza A(H1N1)pdm2009 (41%) and pre-pandemic A(H1N1) (8%). The primary peak of influ-
enza activity was in June-September in temperate climate countries, with little or no
secondary peak. Tropical climate countries had smaller primary peaks taking place in differ-
ent months and frequently detectable secondary peaks.
Conclusions
We found that good influenza surveillance data exists in Latin America, although improve-
ments can still be made (e.g. a better characterization of influenza B specimens); that influ-
enza B plays a considerable role in the seasonal influenza burden; and that there is
substantial heterogeneity of spatio-temporal patterns of influenza epidemics. To improve
the effectiveness of influenza control measures in Latin America, tropical climate countries
may need to develop innovative prevention strategies specifically tailored to the spatio-tem-
poral patterns of influenza in this region.
Introduction
The study of the epidemiology of influenza and burden of disease has allowed countries to
refine their strategies of control and prevention in the temperate climate regions of the world.
Much less attention has been paid to influenza in the tropical climate countries, partly due to
the belief that the burden of influenza is negligible when compared to other infectious diseases
such as tuberculosis, malaria or AIDS. However, the burden of disease due to influenza has
been found to be high in all countries where it has been measured, regardless of latitude [1–5].
In addition, the lack of reliable surveillance data has hindered a detailed study of the epidemi-
ology of influenza A and B in the tropics, but this has changed in recent years, especially since
the 2009 pandemic.
Several studies have recently compared the spatio-temporal patterns of influenza between
tropical areas within large countries (e.g. Brazil [6–7], India [8] and China [9]) or within geo-
graphical regions in the tropics (e.g. south and south-eastern Asia [10] and Africa [11]). These
studies have provided a better understanding of the climatic and demographic factors that trig-
ger the onset and spread of influenza epidemics, and improved knowledge about the optimal
timing for vaccination.
Latin America is a region with a population of 626 million people that contains much diver-
sity in terms of topography and climate zones. Knowledge regarding the epidemiology of influ-
enza has improved since the 2009 pandemic through an increased availability of good quality
surveillance data; however, some aspects that may have profound implications for influenza
prevention and control strategies still remain unclear and need to be examined in more depth.
Here, we compared the influenza surveillance systems and assessed the epidemiology of
influenza A and B (including the spatio-temporal patterns of influenza epidemics) in ten coun-
tries in Latin America using the database of the Global Influenza B Study.
Epidemiology of seasonal influenza A and B in Latin America
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Materials and methods
Source of data
The Global Influenza B Study (GIBS) was launched in 2012 with the objective of producing sci-
entific evidence needed to support the implementation of effective influenza prevention and
control strategies worldwide. The methodology has been described in detail elsewhere [12].
Briefly, coordinators of national influenza surveillance systems of over fifty countries around
the world (including countries situated in the Northern and Southern hemispheres and in the
inter-tropical belt) were invited between 2013 and 2015 (depending on countries) to provide
virological and epidemiological data on influenza that was collected within their national influ-
enza surveillance system from 2000 until the date of contact. The GIBS has a focus on influenza
B, but because data are collected for both influenza A and B, we can perform epidemiological
analyses for both influenza virus types. The data received include the weekly number of
reported laboratory-confirmed influenza cases (referred to as “cases” hereinafter) broken
down by age group and influenza virus type and subtype/lineage and the weekly rates of influ-
enza-like illness [ILI] or acute respiratory infection [ARI] (depending on availability). Thirty
countries joined the GIBS as of December 2015. Participants were also required to describe
their influenza surveillance system by answering a questionnaire specifically developed for
GIBS. Consent was separately obtained in each country, when necessary, at the stage of data
collection. No further permission is required to analyze the data. Contact information of data
owners is available in S1 File.
We included information on cases by virus type (A, B), subtype (H1N1, H1N1pdm09,
H3N2, not subtyped) and lineage for influenza B (Victoria, Yamagata, non characterized) for
the following sites (including countries and sub-national regions of Latin America): Province
of Santa Fe in Argentina, Brazil Midwest, Brazil North, Brazil Northeast, Brazil South, Brazil
Southeast, Chile, Costa Rica, Ecuador, El Salvador, Guatemala, Honduras, Nicaragua and Pan-
ama (Fig 1). Brazilian datasets included information on the virus type (A, B) but not on the
subtype and lineage. Table 1 outlines the main features of the influenza surveillance systems
that were included in the analysis.
Measures and statistical analysis
We conducted an analysis using data aggregated by year and site. For each site, we initially
included data from all calendar years with year-round influenza surveillance AND with at least
30 reported cases. We calculated the proportion of cases due to each influenza virus in each
site and year. Monthly numbers of cases were standardized per year and divided by the highest
number of cases in a month in the same site and year (hence, months with the highest number
of cases for a given site and year were assigned the value 1); these value were then visualized by
means of a heat map (in which the colour bar represents the intensity of monthly cases). We
then calculated the median proportion of cases that were caused by each influenza virus (sub)
type, and how frequently each of them caused the majority (50% or more) of all cases reported
in a year.
We compared the timing and intensity of the primary and secondary influenza epidemic
peaks between sites. For this analysis we excluded data from 2009, which was markedly atypi-
cal due to the introduction of a novel pandemic strain (A[H1N1]pdm2009). For each site, we
first standardized each time series to proportions of the maximum annual value (so all years
contribute equally). Next we generated a periodic annual function (PAF) of each time series by
summing up the annual, semi-annual and quarterly harmonics as obtained by Fourier decom-
position [13–14]. The timing and amplitude of the primary and secondary peaks of the PAF
Epidemiology of seasonal influenza A and B in Latin America
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were extracted and compared between sites, as based on their latitudinal position. The timing
of the primary and secondary peaks refers to the time of the year when the maximum influenza
activity usually occurs. The amplitude of PAF is obtained by dividing the wave height (differ-
ence between the peak and trough values derived in the model) by the peak value. The peak
amplitude is expressed as a percentage and must be interpreted as the intensity of the seasonal-
ity (when the signal is well defined); owing to how it is calculated, the amplitude can some-
times exceed 100%.
Analyses and figures were generated using the freely available analytical software Epipoi
[14].
Results
Data included in the present analysis originated from surveillance systems covering a popula-
tion of about 270 million people, which corresponds to more than 40% of the total population
of Latin America (Table 1). The proportion of outpatients among all sampled patients varied
between 0% in Ecuador and 5% in Chile, to 56% in Honduras and 72% in Guatemala but
Fig 1. Countries and sub-national regions that were included in the analysis. The Global Influenza B
Study, Latin-American countries, 2003–2014. Dark Blue: Central America. Light Blue: Brazil. Yellow:
remaining sites in South America.
https://doi.org/10.1371/journal.pone.0174592.g001
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respondents reported no significant changes in these percentages over time. All sites per-
formed polymerase chain reaction (PCR) testing for influenza virus detections.
The total number of cases that were available for analysis was 37,087, of which 32,135
(86.6%) were influenza A and 4,952 (13.4%) were influenza B (Table 2). The percentage of
influenza A cases that were subtyped was 82.5%; for influenza B, 15.6% of cases were character-
ized. The study period varied for each site, spanning from four years (Honduras, Costa Rica
and Ecuador) to eight years of data (Brazil Northeast, Southeast and South) (median number
of years of reporting = 6) (Fig 2). The median number of cases reported per year was 146
(range 31–4,072). The ILI rates were available only for Brazil (calculated as proportion of ILI
over the total number of consultations) and Argentina (per 100,000 population) (Table 1).
Cases were unevenly distributed across sites, years and strains. The top contributor was
Chile (n = 10,476, corresponding 28.2% of all cases), with most of the cases from 2009 (38.9%).
The pandemic strain contributed nearly half of the cases, followed by A(H3N2), A not-sub-
typed, B and pre-pandemic A(H1N1) (Table 2). The median percentage of influenza B was
20.5% (inter-quartile range 7.2%-35.3%), which rose to 23.2% (inter-quartile range 8.9%-
37.2%) when ignoring the 2009 year. Influenza B was only rarely the dominant virus: this
occurred in seven of 82 years (in 2008 in Brazil South, in 2010 in Brazil Midwest, South and
Southeast, in 2011 in El Salvador, in 2012 in Nicaragua and Panama). There were 39 (out of
82) years in which A was the dominant virus and in which at least 20% of all influenza A cases
were subtyped: A(H1N1) accounted for the majority of cases in three years (7.7% of all years),
A(H1N1)pdm2009 in sixteen years (41.0%), and A(H3N2) in twenty years (51.3%). The num-
ber of cases by virus type, subtype and lineage in each year and site is available in the S1 Table.
After excluding data from 2009, data of 20,525 cases were available for analysis on timing
and intensity. The timing and amplitude of primary peaks of each site relative to their latitudes
are shown in Table 3 and Fig 3. The timing of the primary peak of influenza activity was well
aligned with the Southern Hemisphere (June-September) for sites located in the temperate
Table 1. Main features of influenza surveillance systems of countries and sub-national regions included in the analysis. The Global Influenza B
Study, Latin-American countries, 2003–2014.
Country Latitude (1) Population
(million)
Representativeness of
data
% of outpatients
(2)
Laboratory methods for influenza
diagnosis
Guatemala 14.6 15.4 National 72% PCR, culture, immunofluorescence
Honduras 14.1 8.2 National 56% PCR, culture, immunofluorescence
El Salvador 13.7 6.1 National 22% PCR, culture, immunofluorescence
Nicaragua 12.1 6.1 National 43% PCR, culture, immunofluorescence
Costa Rica 9.9 4.6 National 27% PCR, culture, immunofluorescence
Panama 9.0 3.7 National 39% PCR, culture, immunofluorescence
Ecuador -0.2 15.4 National 0% PCR
Brazil North -3.1 15.0 National unknown PCR, immunofluorescence
Brazil Northeast -8.1 53.1
Brazil Midwest -16.7 13.3
Brazil Southeast -23.6 80.4
Brazil South -27.6 27.4
Argentina (Santa Fe
Province)
-31.6 3.2 Regional unknown PCR, immunofluorescence
Chile -33.5 16.6 National 5% PCR, culture, immunofluorescence
(1) Latitude of the country centroid (if available) or largest city.
(2) Proportion of outpatients over all patients sampled.
https://doi.org/10.1371/journal.pone.0174592.t001
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climate region (latitude < -23.5: Chile, Argentina, Brazil South and Brazil Southeast). The tim-
ing of the primary peaks of influenza activity in the remaining sites (all within the tropical
belt) had a more complex distribution throughout the year. The seasonality of influenza activ-
ity in Ecuador and in the Northern hemisphere countries of El Salvador, Panama and Hondu-
ras follows that of temperate climate regions in the Southern hemisphere (primary peak
between beginning of July and end of August). The primary peak takes place in early October
in Brazil Midwest, and in November in Nicaragua and Costa Rica. Finally, the North and
Northeast regions of Brazil, Ecuador and Guatemala have their primary peak before May. The
amplitude of the primary peak was above 90% in central-American countries (except Costa
Rica, where it was 88.6%) and sites in the temperate climate region (except Brazil Southeast,
where it was 80.5%), between 80% and 90% in Ecuador (88.6%), and below 80% in Brazil
North, Northeast and Midwest (Table 3).
There were clear secondary peaks (amplitude > 70%) in Guatemala (taking place in early
July), Nicaragua (late June) and Ecuador (late January) (Table 3 and Fig 3). There were milder
yet clearly discernible secondary peaks (amplitude > 50%) in Honduras (March-April), Costa
Rica (early July) and Brazil Midwest (end of June). The amplitude of secondary peaks was
below 30% in all other sites.
Discussion
We compared the main characteristics of influenza surveillance systems, assessed the relative
contribution of the different virus (sub)types to influenza epidemics, and investigated the sea-
sonal patterns of influenza circulation, in selected countries of Latin America (including sub-
national data for Brazil) in recent years (2004–2014). The A(H3N2) virus strain was dominant
during most years (except 2009), however influenza B played a considerable role in the
Table 2. Laboratory-confirmed influenza cases by country and virus type, subtype and lineage. The Global Influenza B Study, Latin-American coun-
tries, 2003–2014.
Country Years with
data (a)
No.
cases
A(H1N1) A(H1N1)
pdm2009
A(H3N2) A not
subtyped
B Victoria B
Yamagata
B not
characterized
Guatemala 2007–2012 3,921 308 1,708 377 1,053 0 0 475
Honduras 2009–2012 1,701 0 800 377 351 0 0 173
El Salvador 2007–2012 2,271 8 897 299 575 0 0 492
Nicaragua 2008–2012 4,818 141 2,888 638 442 0 0 709
Costa Rica 2009–2012 6,083 14 4,404 1,077 74 0 0 514
Panama 2008–2013 2,191 0 888 344 636 0 0 323
Ecuador 2011–2014 1,872 0 741 767 34 0 13 317
Brazil North 2007–2012 332 0 0 0 251 0 0 81
Brazil Northeast 2004–2012 866 0 0 0 620 0 0 246
Brazil Midwest 2006–2012 403 0 0 0 313 0 0 90
Brazil Southeast 2004–2012 572 0 0 0 418 0 0 154
Brazil South 2004–2012 974 0 0 0 694 0 0 280
Argentina (Santa Fe
Province)
2003–2012 607 0 101 242 126 111 4 23
Chile 2008–2012 10,476 414 5,491 3,583 41 233 413 301
Total 37,087 885
(2.4%)
17,918
(48.3%)
7,704
(20.8%)
5,628
(15.2%)
344
(0.9%)
430 (1.2%) 4,178 (11.3%)
(a) The following years were not included in the analysis because of fewer than 50 cases of influenza were reported: 2008 for Brazil North and Brazil
Northeast, 2005 for Brazil Southeast and Brazil South, 2006–2009 for Argentina.
https://doi.org/10.1371/journal.pone.0174592.t002
Epidemiology of seasonal influenza A and B in Latin America
PLOS ONE | https://doi.org/10.1371/journal.pone.0174592 March 27, 2017 6 / 12
seasonal influenza burden as it was responsible for around one fourth of all cases in a year on
average. Finally, there was evidence of a substantial heterogeneity of both the amplitude and
the timing of primary and secondary epidemic peaks across countries and sub-national regions
in Latin America.
In the World Health Organization (WHO) Region of the Americas, influenza surveillance
capacity has expanded following the 2009 pandemics, and the use of real-time PCR assays has
become commonplace in the detection of influenza viruses in most countries. Despite
Fig 2. Heat map of monthly influenza virus incidence patterns, 2003–2014, sorted by latitude. The
Global Influenza B Study, Latin-American countries, 2003–2014.
https://doi.org/10.1371/journal.pone.0174592.g002
Table 3. Timing and amplitude of primary and secondary peaks of seasonal influenza epidemics. The Global Influenza B Study, Latin-American coun-
tries, 2003–2014.
Sites Availability of data (a) Latitude (degrees) Primary Peak Secondary Peak
Timing (Month) Amplitude Timing (Month) Amplitude
Guatemala 2007–2012 14.6 Mar 91.7% Jul 82.9%
Honduras 2009–2012 14.1 Aug 96.8% Apr 54.7%
El Salvador 2007–2012 13.7 Jul 99.4% Feb 8.5%
Nicaragua 2008–2012 12.1 Nov 110.1% Jun 72.8%
Costa Rica 2009–2012 9.9 Nov 88.6% Jul 53.0%
Panama 2008–2013 9.0 Jul 107.8% Nov 21.5%
Ecuador 2011–2014 -0.2 Aug 86.2% Jan 75.1%
Brazil North 2007–2012 -3.1 Apr 63.5% Aug 20.0%
Brazil Northeast 2004–2012 -8.1 Apr 61.3% Sep 7.6%
Brazil Midwest 2006–2012 -16.7 Oct 73.8% Jul 53.7%
Brazil Southeast 2004–2012 -23.6 Jun 80.5% Nov 27.3%
Brazil South 2004–2012 -27.6 Jul 95.7% Nov 17.2%
Argentina (Santa Fe) 2003–2012 -31.6 Aug 102.9% - 0.0%
Chile 2008–2012 -33.5 Aug 104.5% Dec 21.5%
(a) Data from the pandemic year of 2009 was not included in the analyses
https://doi.org/10.1371/journal.pone.0174592.t003
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considerable progress made in recent years, influenza surveillance is, however, not uniform
throughout the region, and some gaps persist that need to be addressed by national and supra-
national health agencies. For instance, community- and hospital-based surveillance systems of
respiratory pathogens (including influenza) should ideally be both in place everywhere as they
both provide valuable yet complementary information [15–16]; it appears, however, that the
former is still underdeveloped in several countries in the region. Unlike influenza A, a very
limited percentage of influenza B cases were characterized. It should be noted though that
since 2014 many NICs in Latin America have begun to characterize influenza B cases in a sys-
tematic way, after the US-CDC provided them with PCR assays for virus lineage differentia-
tion, and this situation will likely improve in the coming years. Finally, denominator data were
available for only two out of ten sites included in the study. Overcoming these limitations
would allow an even better monitoring of influenza activity in Latin America and a more in-
depth study of influenza patterns and disease burden, with potentially large public health
impact.
Nearly half of all cases in our database were caused by the A(H1N1) pandemic strain. This
was most likely a consequence of the increased sampling intensity during the pandemic: in
effect, the majority of years were dominated by influenza A(H3N2), both before and after
2009. Influenza B was rarely the dominant virus, but it accounted for a quarter of all cases,
which is in line with what has been reported in temperate countries of Northern and Southern
hemispheres for the same period [12,17–19].
Our findings on the heterogeneity of influenza activity in Latin American countries do not
necessarily affect the most recent recommendations on influenza vaccination (i.e. vaccinating
in April using the Southern hemisphere formulation in all countries except Mexico and Cuba)
[20]. However, it is critical to note that the proportion of cases preventable with a single dose
of influenza vaccine administered in April-May will vary considerably between countries and
across years within the same country. This observation appears even more evident when con-
sidering the poor temporal overlap of influenza A and B epidemics [21] and the rapid decline
of vaccine-induced immunity during a single year [22–23]. Once the WHO goals for influenza
Fig 3. Timing and amplitude of primary (circles) and secondary (triangles) peak of influenza detection
by site, against their latitudinal position. The size corresponds to the amplitude of influenza
seasonality. Dark Blue: Central America. Light Blue: Brazil. Yellow: remaining sites in South America.
https://doi.org/10.1371/journal.pone.0174592.g003
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vaccine coverage among vulnerable people are met, it will probably be necessary to reflect on
what strategies could further reduce the burden of influenza in this part of Latin America,
especially in tropical countries with two influenza activity peaks per year.
The identification of large areas encompassing countries or sub-national regions with a
similar timing of influenza epidemics has implications for the organization of surveillance sys-
tems and the implementation of influenza vaccination campaigns. Overall, the partition into
three large transmission zones that was made by WHO (Central America Caribbean from
Mexico in the North to Panama in the South; Tropical South America from Colombia in the
North to Peru, Bolivia and Brazil in the South; and Temperate South America including Chile,
Argentina, Uruguay and Paraguay) [24] does not seem fully appropriate as it overlooks some
of the differences we observed (for example, between regions in Brazil and between neighbour-
ing countries in central America). Data from the literature for countries not included in our
database [20, 25–27] provide further support for this view.
An important strength of our study is the availability of influenza surveillance data from
countries and sub-national regions (for Brazil) spanning on a large range of latitudes and very
diverse in terms of their geographical and climatic characteristics. Considering the uniform
use of PCR, the potential bias of different laboratory testing biases are reduced. The use of sta-
tistical methods to account for high (or low) intensity years (e.g. the PAF) and the analysis of
data by year also reduced the potential bias of larger years. Our study also has several limita-
tions. The surveillance systems differ across countries, in particular for what concerns the per-
centage of in- and out-patients; however, this should not affect the results of our spatio-
temporal analysis, because the timing of virus activity is likely to be similar for mild and severe
cases. Influenza surveillance data was available for a limited number of years for some sites.
The epidemiological parameters (timing and amplitude of primary and secondary peak) that
we estimated may change by extending the study period by a few years, although we believe
that this would not lead to major changes in our conclusions. Information on lineage was
available for only a few influenza B cases, which prevented us from assessing the level of co-cir-
culation of both lineages and the frequency of influenza B lineage-level vaccine mismatch.
Finally, we had no data available for some large and densely populated countries like Colom-
bia, Venezuela and Peru.
In conclusion, the substantial heterogeneity of spatio-temporal patterns of influenza epi-
demics between countries of Latin America, especially those located in tropical regions,
implies that the effectiveness of the annual seasonal influenza vaccine may be moderate or low
in some countries and some years. In tropical countries or regions where there is little season-
ality and/or bimodal epidemic curves, effectiveness may be consistently low because protection
may not have time to develop, or have already fallen, when influenza activity peaks. These lat-
ter findings call for a reflection on how to move beyond the limits of applying existing influ-
enza prevention strategies that have proved effective in temperate climates to tropical areas of
Latin America.
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